Package 62332-224-08

{"route": ["ORAL"], "spl_id": "0f406336-e614-4427-89c7-bd26d3792590", "openfda": {"unii": ["CR02EYQ8GV"], "rxcui": ["485421", "485423"], "spl_set_id": ["9f6952c8-e547-4f3e-a978-a88d6ea9dc10"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "8 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (62332-224-08)", "package_ndc": "62332-224-08", "marketing_start_date": "20171212"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-224-30)", "package_ndc": "62332-224-30", "marketing_start_date": "20171212"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-224-90)", "package_ndc": "62332-224-90", "marketing_start_date": "20171212"}, {"sample": false, "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-224-91)", "package_ndc": "62332-224-91", "marketing_start_date": "20171212"}], "brand_name": "DARIFENACIN", "product_id": "62332-224_0f406336-e614-4427-89c7-bd26d3792590", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "62332-224", "generic_name": "DARIFENACIN", "labeler_name": "Alembic Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DARIFENACIN", "active_ingredients": [{"name": "DARIFENACIN HYDROBROMIDE", "strength": "15 mg/1"}], "application_number": "ANDA207681", "marketing_category": "ANDA", "marketing_start_date": "20171212", "listing_expiration_date": "20261231"}